P. Hunt

1-Alkyl-1,2,5,6-tetrahydropyridine-3-carboxaldehyde-O-alkyl-oximes: a new class of potent orally active muscarinic agonists related to arecoline

M. Fortin, A. Maggioni, F. Barzaghi, 1991 .

Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit.

R. Mckernan, J. Atack, K. Wafford, 2005, Journal of medicinal chemistry.

Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.

V. Matassa, M. Beer, J. Stanton, 1999, Journal of medicinal chemistry.

Identification of a Novel Allosteric Inhibitory Site on Tryptophan Hydroxylase 1 Enabling Unprecedented Selectivity Over all Related Hydroxylases

Matthew Thomas, David Rowlands, Clemens Scheufler, 2017, Front. Pharmacol..

3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.

V. Matassa, M. Beer, J. Stanton, 1999, Journal of medicinal chemistry.

1-substituted-1,2,5,6-tetrahydropyridine-3-carboxaldehyde-O-alkyloximes as novel orally active and long-lasting muscarinic cholinergic agonists

M. Fortin, A. Maggioni, F. Barzaghi, 1992 .

The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonists.

D. O'connor, S. Watson, S. Charlton, 2014, Bioorganic & medicinal chemistry letters.

Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT(1A) and 5-HT re-uptake ligands.

R. Mortishire-Smith, D. O'connor, D. C. Evans, 1999, Bioorganic & medicinal chemistry letters.